case_images: PMC11128603_01
case_images: PMC11128603_02
case_images: Related indexes of the patient at different time points. (A-G) Temperature (A), WBC (B), HB (C), PLT (D), ferritin (E), IL-6 (F), and CAR-T cell count (G) in the peripheral blood of the patient on days 2, 4, 6, 8, 10, and 12 after CAR-T therapy. WBC, white blood cell; HB, hemoglobin; PLT, platelet.
case_images: fimmu-15-1389227-g001.jpg
case_images: PMC11128603_02_fimmu-15-1389227-g001.jpg
case_images: f1
case_images: On day 8 after CAR-T therapy, the patient developed a fever with a maximum temperature of 39.2 C, which subsided on day 10 after 10 mg of intravenous dexamethasone ( Figure 1A ). The patient had a severe reduction in whole blood cells ( Figures 1B-D ) with a mild increase in ferritin and interleukin-6 (IL-6) levels ( Figures 1E, F ). CAR-T cell counts in the peripheral blood are shown in  Figure 1G .
case_images: Timeline of the patient's treatment and bone marrow assessment. DA, daunorubicin and cytarabine; HDAC, high-dose cytarabine; Ven, venetoclax; Aza, azacytidine; Flu, fludarabine; Cy, cyclophosphamide.
case_images: fimmu-15-1389227-g002.jpg
case_images: PMC11128603_02_fimmu-15-1389227-g002.jpg
case_images: f2